James Engelhart
Director/Board Member bij Our Lady of Mercy Academy
Profiel
De heer James Engelhart, CPA, is Chief Financial Officer & Treasurer bij Biohaven Pharmaceutical Holding Co. Ltd. Hij zit in de Raad van Bestuur van Our Lady of Mercy Academy. De heer Engelhart was voorheen werkzaam als Uitvoerend Directeur-Financiën bij Alexion Pharmaceuticals, Inc., Financieel Directeur bij Energizer SpinCo, Inc., en als Auditor bij Coopers & Lybrand LLP. Hij behaalde zijn bachelordiploma aan de Villanova University en een bachelordiploma aan de Villanova School of Business.
Actieve functies van James Engelhart
| Bedrijven | Functie | Begin |
|---|---|---|
| Our Lady of Mercy Academy | Director/Board Member | - |
Eerdere bekende functies van James Engelhart
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 15-12-2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2016 |
| ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 01-07-2014 |
| Coopers & Lybrand LLP | Corporate Officer/Principal | 01-01-1991 |
Opleiding van James Engelhart
| Villanova School of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
| Bedrijven in privébezit | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| Our Lady of Mercy Academy |
